Stocks / NASDAQ / Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc.

Our Opinion

Kezar Life Sciences, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for medical analysis and clinical research purpose.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“KZR-616 is a immunoproteasome inhibitor that the company says delivers a broad anti-inflammatory response and has shown potential efficacy in reducing certain autoimmune diseases (e.g., lupus, rheumatoid arthritis, IBD, MS, type 1 diabetes) in animal models.” Read the full document

Company Description

Company Website: